Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Dropped -1.2% – Here’s Why

      Comments Off on Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Dropped -1.2% – Here’s Why

In its latest trading session, Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) dropped by -1.2% – here is what that looked like (as of 2020-01-06):

What is the cause of all this?? To have a greater insight of what is happening, it is helpful to analyze some technical indicators. As we see it, you should pay the most attention to the following:

A Money Flow Index (MFI) of 100.0, a Relative Strength Index (RSI) of 50.0, a True Strength Index (TSI) of 100.0, a Moving Average Convergence Divergence (MACD) of 0.015, an Average Directional Movement Index (ADX) of unknown, an Average True Range (ATR) of 0.295, an Accumulation/Distribution Index (ADI) of 0.295, an On-Balance Volume (OBV) of 173.938, and a Chaiikin Money Flow (CMF) of 14.55. 2.926

Now let’s plug these indicators in. Consulting Trading View, we can conclude the following:

So when putting all the technical indicators together, this is what you get. And finally, make sure to DO YOUR OWN RESEARCH! Take the above with a grain of salt, and do your own research.